Connect with us

Technology

Hospital PMI® at 58.4%; May 2024 Hospital ISM® Report On Business®

Published

on

TEMPE, Ariz., June 7, 2024 /PRNewswire/ — Economic activity in the hospital subsector grew in May for the ninth consecutive month after contracting twice in the previous four-month period, with 35 consecutive months of growth prior to that, say the nation’s hospital supply executives in the latest Hospital ISM® Report On Business®.

The report was issued today by Nancy LeMaster, MBA, Chair of the Institute for Supply Management® (ISM®) Hospital Business Survey Committee: “The Hospital PMI® registered 58.4 percent in May, a 4.9-percentage point increase from the April reading of 53.5 percent, indicating a ninth consecutive month of growth after a contraction in August. The Business Activity Index expanded for the ninth consecutive month. The New Orders Index remained in expansion for the ninth straight month, and the Employment Index moved back into growth territory. The Supplier Deliveries Index remained in expansion (which indicates slower delivery performance). The Case Mix Index expanded in May after contracting in April, registering 51.5 percent, an increase of 2.5 percentage points compared to the previous month’s figure of 49 percent. The Days Payable Outstanding Index remained in expansion territory in May, registering 57 percent, up 4.5 percentage points from the 52.5 percent reported in April. The Technology Spend Index reading of 60.5 percent is an increase of 6 percentage points compared to the 54.5 percent recorded in April. The Touchless Orders Index returned to contraction territory in May, registering 48.5 percent, down 3 percentage points from the 51.5 percent reported in April.”

LeMaster continues, “Strong volumes were top of mind for Hospital Business Survey Committee respondents. Underlying causes cited for the higher volumes included boosts in physician staffing, expanded physical capacity, a rebound from slow spring break traffic and the introduction of new treatments and technologies. Comments related to supply chain operations were more varied. Facilities in some parts of the country enjoyed stability in deliveries and pricing, while others continued to experience shortages and inflationary pressure. Shortages related to syringes due to production issues in China were widespread, as were shortages in sterile water and saline. The Employment Index indicated growth, but comments continued to reflect mixed results. Some panelists indicated their facilities were keeping positions open, while others reported strong hiring efforts designed to replace temporary labor. For the first time since the coronavirus pandemic, construction projects were a theme among panelists’ comments. Previously, mentions of capacity growth had been related to M&As.”

Hospital PMI® History

Month

Hospital PMI®

Month

Hospital PMI®

May 2024

58.4

Nov 2023

59.8

Apr 2024

53.5

Oct 2023

52.1

Mar 2024

52.3

Sep 2023

57.0

Feb 2024

56.6

Aug 2023

47.5

Jan 2024

61.5

Jul 2023

53.3

Dec 2023

62.5

Jun 2023

51.5

Average for 12 months – 55.5

High – 62.5

Low – 47.5

 

About This Report
The information compiled in this report is for the month of May 2024.

The Hospital PMI® was developed in collaboration with the Association for Health Care Resource & Materials Management (AHRMM), an association for the health care supply chain profession, and a professional membership group of the American Hospital Association (AHA).

The data presented herein is obtained from a survey of hospital supply executives based on information they have collected within their respective organizations. ISM® makes no representation, other than that stated within this release, regarding the individual company data collection procedures. The data should be compared to all other economic data sources when used in decision-making.

Data and Method of Presentation
The Hospital ISM® Report On Business® is based on data compiled from hospital purchasing and supply executives nationwide. Survey responses reflect the change, if any, in the current month compared to the previous month. For each of the indicators measured (Business Activity, New Orders, Employment, Supplier Deliveries, Inventories, Prices, Prices: Pharmaceuticals, Prices: Supplies, Backlog of Orders, Imports, Inventory Sentiment, Case Mix, Days Payable Outstanding, Technology Spend, and Touchless Orders), this report shows the percentage reporting each response and the diffusion index. Responses represent raw data and are never changed. Beginning in January 2021, the Report On Business® staff and consultants are gathering market information to better validate the Exports Index. Exports Index data are still being collected.

The Hospital PMI® is a composite index computed from the following, equally weighted indexes: Business Activity, New Orders, Employment and Supplier Deliveries. Diffusion indexes have the properties of leading indicators and are convenient summary measures showing the prevailing direction of change and the scope of change. A Hospital PMI® index reading above 50 percent indicates that the hospital sub-sector is generally expanding; below 50 percent indicates that it is generally declining. For the sub-indexes, except Supplier Deliveries, an index reading above 50 percent indicates that the sub-index is generally expanding; below 50 percent indicates that it is generally contracting. A Supplier Deliveries Index above 50 percent indicates slower deliveries and below 50 percent indicates faster deliveries.

The Hospital ISM® Report On Business® survey is sent out to the Hospital Business Survey Committee respondents the first part of each month. Respondents are asked to ONLY report on U.S. operations for the current month. ISM® receives survey responses throughout most of any given month, with the majority of respondents generally waiting until late in the month to submit responses to give the most accurate picture of current business activity. ISM® then compiles the report for release on the fifth business day of the following month.

ISM ROB Content
The Institute for Supply Management® (“ISM”) Report On Business® (Manufacturing, Services, and Hospital reports) (“ISM ROB”) contains information, text, files, images, video, sounds, musical works, works of authorship, applications, and any other materials or content (collectively, “Content”) of ISM (“ISM ROB Content”). ISM ROB Content is protected by copyright, trademark, trade secret, and other laws, and as between you and ISM, ISM owns and retains all rights in the ISM ROB Content. ISM hereby grants you a limited, revocable, nonsublicensable license to access and display on your individual device the ISM ROB Content (excluding any software code) solely for your personal, non-commercial use. The ISM ROB Content shall also contain Content of users and other ISM licensors. Except as provided herein or as explicitly allowed in writing by ISM, you shall not copy, download, stream, capture, reproduce, duplicate, archive, upload, modify, translate, publish, broadcast, transmit, retransmit, distribute, perform, display, sell, or otherwise use any ISM ROB Content.

Except as explicitly and expressly permitted by ISM, you are strictly prohibited from creating works or materials (including, but not limited to tables, charts, data streams, time-series variables, fonts, icons, link buttons, wallpaper, desktop themes, online postcards, montages, mashups and similar videos, greeting cards, and unlicensed merchandise) that derive from or are based on the ISM ROB Content. This prohibition applies regardless of whether the derivative works or materials are sold, bartered, or given away. You shall not either directly or through the use of any device, software, internet site, web-based service, or other means remove, alter, bypass, avoid, interfere with, or circumvent any copyright, trademark, or other proprietary notices marked on the Content or any digital rights management mechanism, device, or other content protection or access control measure associated with the Content including geo-filtering mechanisms. Without prior written authorization from ISM, you shall not build a business utilizing the Content, whether or not for profit.

You shall not create, recreate, distribute, incorporate in other work, or advertise an index of any portion of the Content unless you receive prior written authorization from ISM. Requests for permission to reproduce or distribute ISM ROB Content can be made by contacting Rose Marie Goupil in writing at: ISM Research, Institute for Supply Management, 309 W. Elliot Road, Suite 113, Tempe, AZ 85284-1556, or by emailing rgoupil@ismworld.org; Subject: Content Request.

ISM shall not have any liability, duty, or obligation for or relating to the ISM ROB Content or other information contained herein, any errors, inaccuracies, omissions or delays in providing any ISM ROB Content, or for any actions taken in reliance thereon. In no event shall ISM be liable for any special, incidental, or consequential damages, arising out of the use of the ISM ROB. Report On Business®, PMI®, Manufacturing PMI®, Services PMI®, and Hospital PMI® are registered trademarks and trademarks of Institute for Supply Management®. Institute for Supply Management® and ISM® are registered trademarks of Institute for Supply Management, Inc.

About Institute for Supply Management®
Institute for Supply Management® (ISM®) is the first and leading not-for-profit professional supply management organization worldwide. Its community of more than 50,000 in more than 100 countries manage about US$1 trillion in corporate and government supply chain procurement annually. Founded in 1915 by practitioners, ISM is committed to advancing the practice of supply management to drive value and competitive advantage for its members, contributing to a prosperous and sustainable world. ISM empowers and leads the profession through the ISM® Report On Business®, its highly-regarded certification and training programs, corporate services, events, and assessments. The ISM® Report On Business®, Manufacturing, Services, and Hospital, are three of the most reliable economic indicators available, providing guidance to supply management professionals, economists, analysts, and government and business leaders. For more information, please visit: www.ismworld.org.

The text version of the public Hospital ISM® Report On Business® is posted on ISM®’s website at www.ismrob.org on the fifth business day* of every month at 10:00 a.m. ET.

The next Hospital ISM® Report On Business® featuring June 2024 data will be released at 10:00 a.m. ET on Friday, July 5, 2024.

*Unless the New York Stock Exchange is closed.

Contact:

Rose Marie Goupil

Report On Business® Analyst

ISM®, ROB/Program Manager

Tempe, Arizona

+1 480.752.6276, ext. 3005

Email: rgoupil@ismworld.org

 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/hospital-pmi-at-58-4-may-2024-hospital-ism-report-on-business-302166554.html

SOURCE Institute for Supply Management

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Immorta Bio to Present New Data on SenoVax™ and StemCell Revivify™ at Biotech Showcase 2025

Published

on

By

Senolytic Immunotherapy and Cellular Rejuvenation platforms are progressing toward clinical development

MIAMI, Jan. 10, 2025 /PRNewswire/ — Immorta Bio Inc., a leader in longevity-focused biotechnologies, announced today that it will present its latest developments at the upcoming Biotech Showcase in San Francisco, CA. The company’s presentation will provide insights into its groundbreaking research and technological advancements aimed at Treating Diseases of Aging and Treating Aging as Disease™.

Details of the presentation are as follows:

Event: Biotech Showcase 2025
Date: January 14, 2025
Time: 4 PM Pacific
Location: Franciscan C, Ballroom Level

Immorta Bio’s innovative platform SenoVax™, a dendritic cell-based vaccine designed to target and eliminate senescent cells. Preclinical studies have demonstrated its potential to transform the tumor microenvironment by clearing these cells, which are associated with aging and disease progression. Furthermore, in animal models of multiple solid tumor cancers (lung, breast, glioma, pancreatic), SenoVax™ induced significant tumor regression by enhancing immune responses, underscoring its promise as a therapeutic solution for both cancer treatment and longevity research.

The company’s StemCell Revivify™, a set of personalized young and immortal progenitor and mesenchymal stem cells have shown an ability to achieve dramatic recovery of failing organs in multiple animal models. Proprietary iPSC-based stem cell therapies have been developed to provide scalable, practical, and economical solutions.

“We are thrilled to showcase our recent progress and share our vision for tackling the diseases of aging as well as the aging itself,” said Dr. Thomas Ichim, President and Chief Scientific Officer of Immorta Bio. “At Immorta Bio, we believe that combining cutting-edge science with a deep understanding of the biology of aging can transform how we address major medical challenges. The Biotech Showcase offers an invaluable platform to engage with innovators, collaborators, and investors while we highlight how our breakthroughs in longevity science are paving the way for healthier, longer lives.”

To learn more about the event, please visit https://informaconnect.com/biotech-showcase/. To schedule a one-on-one with Dr. Thomas Ichim, President and Chief Scientific Officer of Immorta Bio, during the event, please email kbash@immortabio.com

About Immorta Bio
Immorta Bio Inc. is a scientific longevity company developing personalized cellular therapeutics focused on Treating Diseases of Aging and Treating Aging as a Disease™. We are advancing longevity medicine by harnessing patient-derived rejuvenated stem cells and enhanced immune cells, restoring the body’s natural ability to combat cancers and age-related diseases. Our mission is to address the root causes of aging and bring resilience and vitality back to you.

To learn more about Immorta Bio’s research initiatives, visit immortabio.comLinkedIn and X.

Media Contact

David Schull  
Russo Partners
858-717-2310
388575@email4pr.com

Kate Bash
Chief Commercial Officer
Immorta Bio
388575@email4pr.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/immorta-bio-to-present-new-data-on-senovax-and-stemcell-revivify-at-biotech-showcase-2025-302347953.html

SOURCE Immorta Bio Inc.

Continue Reading

Technology

Breaking Stereotypes: New 3Fun Survey Reveals Media’s Missteps in Polyamory Representation

Published

on

By

NEW YORK, Jan. 10, 2025 /PRNewswire/ — Despite growing visibility, only 11% of polyamorous individuals feel media portrayals align with their real-life experiences, according to a new survey by 3Fun, the leading dating app for open-minded singles and partners seeking like-minded connections. The survey, conducted among 1,312 3Fun users, highlights how media misrepresentation shapes public perceptions, reinforces stereotypes, and impacts user expectations on dating platforms like 3Fun.

Key Findings from the 3Fun Survey:

Limited Representation: Nearly 40% of respondents said they rarely see polyamorous relationships in mainstream media, while 17% reported never seeing them at all.Social Media Influence: Platforms like Instagram and TikTok are driving perceptions of polyamory for 40% of users, far surpassing traditional media like TV and film (10%).Accuracy Issues: Only 11% of respondents described media portrayals as “very accurate,” while 52% rated them as “rarely accurate” or “completely inaccurate.”Mixed Progress: While 39% believe portrayals have improved, 38% said they’ve noticed no change at all.Normalization vs. Stereotypes: Social media is a double-edged sword—40% think it normalizes polyamory, but 34% believe it reinforces harmful stereotypes.Global vs. Local Media: Over 21% noted global media tends to be more open-minded about polyamory than local outlets, which are often conservative or avoid the topic altogether.

“The data from this survey shows how far we still have to go in achieving authentic representation of polyamory in media and pop culture,” said Max Ma, Founder and CEO of 3Fun. “These portrayals don’t just shape public opinion—they directly influence how our users feel about their relationships and their ability to live openly. At 3Fun, we’re dedicated to creating a supportive community where everyone can explore their desires without fear of judgment.”

The Real Impact of Misrepresentation

Nearly half of respondents (47%) identified cultural and societal norms as the biggest barriers to societal acceptance of polyamory—more significant than concerns about media portrayal or visibility. However, respondents emphasized that better representation would lead to:

Easier conversations about polyamory (32%)Improved understanding within their social circles (21%)

Gigi Engle, certified sex and relationship psychotherapist and 3Fun’s resident intimacy expert, echoed this sentiment: “Representation matters. Media has the power to normalize relationships and dismantle stereotypes, but only when done thoughtfully. This survey shows a clear need for creators to approach polyamory with authenticity and care.”

Creating a World Where Love Knows No Limits

The findings highlight the role platforms like 3Fun play in bridging the gap between perception and reality. With over 10 million downloads and 3 million verified active users worldwide, 3Fun provides a safe, inclusive space for polyamorous individuals and couples to connect, explore, and thrive.

Join us in building a community where love is celebrated in all its forms. Download 3Fun today and discover a world where love knows no limits.

For more information, visit www.go3fun.co.

About 3Fun:

3Fun, with over 10 million downloads and 3 million verified active users worldwide, is the leading dating app for open-minded singles and partners to meet like-minded people. The platform provides a safe and inclusive space for users to explore ethical open relationships and polyamory lifestyles, fostering community and connection without judgment. Learn more at www.go3fun.co.

Media Contact:
Britni Ackrivo
backrivo@gregoryfca.com
484-504-9920

View original content:https://www.prnewswire.com/news-releases/breaking-stereotypes-new-3fun-survey-reveals-medias-missteps-in-polyamory-representation-302347759.html

SOURCE 3Fun

Continue Reading

Technology

Powerfleet to Present at the 27th Annual Needham Growth Conference

Published

on

By

WOODCLIFF LAKE, N.J., Jan. 10, 2025 /PRNewswire/ — Powerfleet, Inc. (Nasdaq: AIOT) today announced that management is scheduled to present at the 27th Annual Needham Growth Conference on Tuesday, January 14th at 4:30pmET and meet with investors to discuss how Powerfleet is enacting meaningful business change through effective data insights for its customers and underpinning their digital transformations.  

The link to the live webcast of the Company’s presentation will be available by visiting Powerfleets website at https://ir.powerfleet.com/events-presentations/events.

ABOUT POWERFLEET
Powerfleet (Nasdaq: AIOT; JSE: PWR) is a global leader in the artificial intelligence of things (AIoT) software-as-a-service (SaaS) mobile asset industry. With more than 30 years of experience, Powerfleet unifies business operations through the ingestion, harmonization, and integration of data, irrespective of source, and delivers actionable insights to help companies save lives, time, and money. Powerfleet’s ethos transcends our data ecosystem and commitment to innovation; our people-centric approach empowers our customers to realize impactful and sustained business improvement. The company is headquartered in New Jersey, United States, with offices around the globe. Explore more at www.powerfleet.com. Powerfleet has a primary listing on The Nasdaq Global Market and a secondary listing on the Main Board of the Johannesburg Stock Exchange (JSE).

Powerfleet Investor Contacts
Carolyn Capaccio and Jody Burfening
Alliance Advisors IR
AIOTIRTeam@allianceadvisors.com

Powerfleet Media Contact
Jonathan Bates
jonathan.bates@powerfleet.com
+44 7921 242 892

View original content to download multimedia:https://www.prnewswire.com/news-releases/powerfleet-to-present-at-the-27th-annual-needham-growth-conference-302347520.html

SOURCE Powerfleet

Continue Reading

Trending